Sweet 'n' sour: The impact of differential glycosylation on T cell responses

Nature Immunology

Volumn 3, Issue 10, 2002, Pages 903-910

  Daniels, Mark A ^a   Hogquist, Kristin A ^a   Jameson, Stephen C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GALECTIN; SELECTIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOREACTIVITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD43; GALECTINS; GLYCOSYLATION; HEMAGGLUTININS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; SELECTINS; SIALOGLYCOPROTEINS; T-LYMPHOCYTES;

EID: 0036793242     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1002-903     Document Type: Review

References (137)

1. Lowe, J.B. Glycosylation, immunity, and autoimmunity. Cell 104, 809-812 (2001).
2. Rudd, P.M. et al. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J. Mol. Biol. 293, 351-366 (1999).
3. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I.A. & Dwek, R.A. Glycosylation and the immune system. Science 291, 2370-2376 (2001).
4. Varki, A. et al. (eds.) Essentials of Glycobiology (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999).
5. Crocker, P.R. & Varki, A. Siglecs, sialic acids and innate immunity. Trends Immunol. 22, 337-342 (2001).
6. Rabinovich, G. A. et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23, 313-320 (2002).
7. Grogan, M. J., Pratt, M. R., Marcaurelle, L.A. & Bertozzi, C. R. Homogeneous glycopeptides and glycoproteins for biological investigation. Annu. Rev. Biochem. 71, 593-634 (2002).
8. Marth, J. D. Will the transgenic mouse serve as a Rosetta Stone to glycoconjugate function? Glycocon. J. 11, 3-8 (1994).
9. Lowe, J.B. & Marth, J.D. Genetic approaches to carbohydrate function. Annu. Rev. Biochem. (in the press, 2003).
10. Despont, J.P., Abel, C.A. & Grey, H.M. Sialic acids and sialyltransferases in murine lymphoid cells: indicators of T cell maturation. Cell. Immunol. 17, 487-494 (1975).
11. Reisner, Y., Linker-Isreali, M. & Sharon, N. Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin. Cell. Immunol. 25, 129-134 (1976).
12. Pink, J. R. Changes in T-lymphocyte glycoprotein structures associated with differentiation. Contemp. Top. Mol. Immunol. 9, 89-113 (1983).
13. Toporowicz, A. & Reisner, Y. Changes in sialyltransferase activity during murine T cell differentiation. Cell. Immunol. 100, 10-19 (1986).
14. Lefrancois, L. Expression of carbohydrate differentiation antigens during ontogeny of the murine thymus. J. Immunol. 139, 2220-2229 (1987).
15. Fowlkes, B. J. et al. Differential binding of fluorescein-labeled lectins to mouse thymocytes: subsets revealed by flow microfluorometry. J. Immunol. 125, 623-630 (1980).
16. + to PNA-phenotype in developing thymocytes. J. Biol. Chem. 268, 3801-3804 (1993).
17. Baum, L. G. et al. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression. J. Biol. Chem. 271, 10793-10799 (1996).
18. +T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12, 273-283 (2000).
19. Martin, L.T., Marth, J. D., Varki, A. & Varki, N. M. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acerylation. J. Biol. Chem. 277, 32930-32938 (2002).
20. Tsuboi, S. & Fukuda, M. Roles of O-linked oligosaccharides in immune responses. Bioessays 23, 46-53 (2001).
21. Baum, L. G. et al. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181, 877-887 (1995).
22. Ellies, L. G., Tao, W., Fellinger, W., Teh, H. S. & Ziltener, H. J. The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection. Blood 88, 1725-1732 (1996).
23. Taira, S. & Nariuchi, H. Possible role of neuraminidase in activated T cells in the recognition of allogeneic Ia. J. Immunol. 141, 440-446 (1988).
24. Chervenak, R. & Cohen, J.J. Peanut lectin binding as a marker for activated T-lineage lymphocytes. Thymus 4, 61-67 (1982).
25. Landolfi, N. F., Leone, J., Womack, J.E. & Cook, R. G. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics 22, 159-167 (1985).
26. Piller, F., Piller, V., Fox, R. I. & Fukuda, M. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J. Biol. Chem. 263, 15146-15150 (1988).
27. + T cells from naive cells. J. Immunol. 161, 641-648 (1998).
28. Kaufmann, M. et al. Identification of an α2,6-sialyltransferase induced early after lymphocyte activation. Int. Immunol. 11, 731-738 (1999).
29. Harrington, L. E., Galvan, M., Baum, L. G., Altman, J. D. & Ahmed, R. Differentiating between memory and effector CD8T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191, 1241-1246 (2000).
30. Siegelman, M. H., DeGrendele, H. C. & Estess, P. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol. 66, 315-321 (1999).
31. Khan, A.A., Bose, C., Yam, L. S., Soloski, M. J. & Rupp, F. Physiological regulation of the immunological synapse by agrin. Science 292, 1681-1686 (2001).
32. Martin, P.T. Glycobiology of the synapse. Glycobiology 12, 1-7 (2002).
33. Trautmann, A. & Vivier, E. Immunology. Agrin-a bridge between the nervous and immune systems. Science 292, 1667-1668 (2001).
34. Shaw, A. S. & Allen, P.M. Kissing cousins: immunological and neurological synapses. Nature Immunol. 2, 575-576 (2001).
35. Demetriou, M., Granovsky, M., Quaggin, S. & Dennis, J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5N-glycosylation. Nature 409, 733-739 (2001).
36. Krishna, M. & Varki, A. 9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation. J. Exp. Med. 185, 1997-2013 (1997).
37. Carlow, D.A., Ardman, B. & Ziltener, H.J. A novel CD8T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. J. Immunol. 163, 1441-1448 (1999).
38. Blander, J.M., Visintin, I., Janeway, C.A. Jr. & Medzhitov, R. A(1,3)-fucosyltransferase VII and α(2,3)-sialyltransferase IV are up-regulated in activated CD4T cells and maintained after their differentiation into Th1 and migration into inflammatory sites. J. Immunol. 163, 3746-3752 (1999).
39. Lim, Y.C. et al. Expression of functional selectin ligands on Th cells is differentially regulated by IL-12 and IL-4. J. Immunol. 162, 3193-3201 (1999).
40. +T cell core 2 β-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. J. Immunol. 167, 4476-4484 (2001).
41. Moody, A.M. et al. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 107, 501-512 (2001).
42. Ellies, L. G. et al. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity 9, 881-890 (1998).
43. Tsuboi. S. & Fukuda, M. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO J. 16, 6364-6373 (1997).
44. Tsuboi, S. & Fukuda, M. Overexpression of branched O-linked oligosaccharides on T cell surface glycoproteins impairs humoral immune responses in transgenic mice. J. Biol. Chem. 273, 30680-30687 (1998).
45. Schwientek, T. et al. Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 β1, 6-n-acetylglucosaminyltransferase. J. Biol. Chem. 275, 11106-11113 (2000).
46. Yeh, J. C., Ong, E. & Fukuda, M. Molecular cloning and expression of a novel β-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and 1 branches. J. Biol. Chem. 274, 3215-3221 (1999).
47. Chen, X. P., Enioutina, E.Y. & Daynes, R.A. The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase. J. Immunol. 158, 3070-3080 (1997).
48. Chen, X. P., Ding, X. & Daynes, R.A. Ganglioside control over IL-4 priming and cytokine production in activated T cells. Cytokine 12, 972-985 (2000).
49. Womack, J. E., Yan, D. L. & Potier, M. Gene for neuraminidase activity on mouse chromosome 17 near h-2: pleiotropic effects on multiple hydrolases. Science 212, 63-65 (1981).
50. Rottier, R. J., Bonten, E. & d'Azzo, A. A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse. Hum. Mol. Genet. 7, 313-321 (1998).
51. Oh, S. & Eichelberger, M. C. Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J. Virol. 74, 7738-7744 (2000).
52. Todeschini, A. R. et al. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling. J. Immunol. 168, 5192-5198 (2002).
53. Penninger, J. M., Irie-Sasaki, J., Sasaki, T. & Oliveira-dos-Santos, A.J. CD45: new jobs for an old acquaintance. Nature Immunol. 2, 389-396 (2001).
54. Janeway, C.A. Jr. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10, 645-674 (1992).
55. T cells differing in CD45R expression. J. Immunol. 149, 2300-2306 (1992).
56. Chui, D., Ong, C.J., Johnson, P., Teh, H.S. & Marth, J. D. Specific CD45 isoforms differentially regulate T cell receptor signaling. EMBO J. 13, 798-807 (1994).
57. Leitenberg, D., Boutin, Y., Lu, D.D. & Bottomly, K. Biochemical association of CD45 with the T cell receptor complex: regulation by CD45 isoform and during T cell activation. Immunity 10, 701-711 (1999).
58. Majeti, R., Bilwes, A. M., Noel, J.P., Hunter, T. & Weiss, A. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279, 88-91 (1998).
59. Majeti, R. et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103, 1059-1070 (2000).
60. Xu, Z. & Weiss, A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nature Immunol. 3, 764-771 (2002).
61. Wu, W., Harley, P. H., Punt, J.A., Sharrow, S. O. & Kearse, K. P. Identification of CD8 as a peanut agglutinin (PNA) receptor molecule on immature thymocytes. J. Exp. Med. 184, 759-764 (1996).
62. Baldwin, T.A. & Ostergaard, H. L. Developmentally regulated changes in glucosidase II association with, and carbohydrate content of, the protein tyrosine phosphatase CD45. J. Immunol. 167, 3829-3835 (2001).
63. Nguyen, J.T. et al. CD45 modulates galectin-I-induced T cell death: regulation by expression of core 2 O-glycans. J. Immunol. 167, 5697-5707 (2001).
64. Hennet, T., Chui, D., Paulson, J. C. & Marth, J. D. Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 95, 4504-4509 (1998).
65. Fouillit, M. et al. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 10, 413-419 (2000).
66. lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 277, 1912-1918 (2002).
67. Kishimoto, H. & Sprent, J. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190, 65-73 (1999).
68. Higgins. E. A., Siminovitch, K. A., Zhuang, D. L., Brockhausen, I. & Dennis, J. W. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol. Chem. 266, 6280-6290 (1991).
69. + T lymphocytes in graft-versus-host disease. Glycobiology 4, 885-893 (1994).
70. Jones, A.T. et al. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. J. Immunol. 153, 3426-3439 (1994).
71. Manjunath, N., Correa, M., Ardman, M. & Ardman, B. Negative regulation of T-cell adhesion and activation by CD43. Nature 377, 535-538 (1995).
72. Ostberg, J. R., Barth, R. K. & Frelinger, J. G. The Roman god Janus: a paradigm for the function of CD43. Immunol. Today 19, 546-550 (1998).
73. He, Y.W. & Bevan, M.J. High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis. J. Exp. Med. 190, 1903-1908 (1999).
74. Sperling, A. I. et al. CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J. Exp. Med. 182, 139-146 (1995).
75. Sperling, A. I. et al. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J. Immunol. 161, 6459-6462 (1998).
76. Stockton, B. M., Cheng, G., Manjunath, N., Ardman, B. & von Andrian, U.H. Negative regulation of T cell homing by CD43. Immunity B, 373-381 (1998).
77. Onami, T.M. et al. Dynamic regulation of T cell immunity by CD43. J. Immunol. 168, 6022-6031 (2002).
78. Carlow, D.A., Corbel, S.Y. & Ziltener, H.J. Absence of CD43 fails to alter T cell development and responsiveness. J. Immunol. 166, 256-261 (2001).
79. Allenspach, E. J. et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 15, 739-750 (2001).
80. Delon, J., Kaibuchi, K. & Germain, R. N. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 15, 691-701 (2001).
81. Roumier, A. et al. The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 15, 715-728 (2001).
82. van den Berg, T. K. et al. Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J. Immunol. 166, 3637-3640 (2001).
83. Cyster, J. G., Shotton, D.M. & Williams, A.F. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10, 893-902 (1991).
84. Fukuda, M. & Carlsson, S. R. Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens. Med. Biol. 64, 335-343 (1986).
85. Shaw, A. S. & Dustin, M. L. Making the T cell receptor go the distance: A topological view Of T cell activation. Immunity 6, 361-369 (1997).
86. Casabo, L. G., Mamalaki, C., Kioussis, D. & Zamoyska, R. T cell activation results in physical modification of the mouse CD8β chain. J. Immunol. 152, 397-404 (1994).
87. Daniels, M.A. et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15, 1051-1061 (2001).
88. O'Rourke, A. M. & Mescher, M. F. The roles of CD8 in cytotoxic T lymphocyte function. Immunol. Today 14, 183-188 (1993).
89. + cells by CD4. Science 249, 1558-1561 (1990).
90. lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 178, 1701-1712 (1993).
91. Baldwin, K. K., Trenchak, B.P., Altman, J. D. & Davis, M. M. Negative selection of T cells occurs throughout thymic development. J. Immunol. 163, 689-698 (1999).
92. Baum, L. G. Developing a taste for sweets. Immunity 16, 5-8 (2002).
93. Gascoigne, N. R. T-cell differentiation: MHC class I's sweet tooth lost on maturity. Curr. Biol. 12, 99-101 (2002).
94. Deck, M. B., Sjolin, P., Unanue, E. R. & Kihlberg, J. MHC-restricted, glycopeptide-specific T cells show specificity for both carbohydrate and peptide residues. J. Immunol. 162, 4740-4744 (1999).
95. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nature Rev. Immunol. 2, 557-568 (2002).
96. + T cells are hyperreactive to antigenic challenge in vitro. J. Exp. Med. 184, 2141-2151 (1996).
97. Davey, G.M. et al. Pre-selection thymocytes are more sensitive to TCR stimulation than mature T cells. J. Exp. Med. 188, 1867-1874 (1998).
98. -) to TCR/CD8 signaling in response to antigen. J. Immunol. 160, 3236-3243 (1998).
99. Lucas, B., Stefanova, I., Yasutomo, K., Dautigny, N. & Germain, R. N. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity 10, 367-376 (1999).
100. Knop, J. Effect of Vibrio cholerae neuraminidase on the mitogen response of T lymphocytes. I. Enhancement of macrophage T-lymphocyte cooperation in concanavalin-A-induced lymphocyte activation. Immunobiology 157, 474-485 (1980).
101. Cullen, S.E., Kindle, C. S., Shreffler, D. C. & Cowing, C. Differential glycosylation of murine B cell and spleen adherent cell 1a antigens. J. Immunol. 127, 1478-1484 (1981).
102. Cowing, C. & Chapdelaine, J. M. T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: a potential function for carbohydrate side chains on 1a molecules. Proc. Natl. Acad. Sci. USA 80, 6000-6004 (1983).
103. Hunig, T. The role of accessory cells in polyclonal T cell activation II. Induction of interleukin 2 responsiveness requires cell-cell contact. Eur J. Immunol. 13, 596-601 (1983).
104. Boog, C. J., Neefjes, J. J., Boes, J., Ploegh, H. L. & Melief, C. J. Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells. Eur J. Immunol. 19, 537-542 (1989).
105. Powell, L D., Whiteheart, S. W. & Hart, G. W. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. J. Immunol. 139, 262-270 (1987).
106. + T cells. Immunol. Rev. 117, 213-234 (1990).
107. Hebert, E. Endogenous lectins as cell surface transducers. Biosc. Rep. 20, 213-237 (2000).
108. Snapp, K. R., Heitzig, C. E., Ellies, L. G., Marth, J. D. & Kansas, G. S. Differential requirements for the O-linked branching enzyme core 2 β1-6-N-glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin. Blood 97, 3806-3811 (2001).
109. Sperandio, M. et al. Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice. Stood 97, 3812-3819 (2001).
110. Yeh, J.C. et al. Novel sulfated lymphocyte homing receptors and their control by a Core I extension β1,3-N-acetylglucasaminyltransferase. Cell 105, 957-969 (2001).
111. Smithson, G. et al. Fuc-TVII is required for T helper I and T cytotoxic I lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes. J. Exp. Med. 194, 601-614 (2001).
112. Homeister, J.W. et al. The α(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 15, 115-126 (2001).
113. Maly, P. et al. The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86, 643-653 (1996).
114. Weninger, W. et al. Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 12, 665-676 (2000).
115. Wagers, A.J., Waters, C. M., Stoolman, L. M. & Kansas, G. S. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on α1,3-fucosyltransferase VII gene expression. J. Exp. Med. 188, 2225-2231 (1998).
116. Carlow, D.A., Corbel, S.Y., Williams, M.J. & Ziltener, H.J. IL-2,-4, and -15 diffierentially regulate O-glycan branching and P-selectin ligand formation in activated CD8T cells. J. Immunol. 167, 6841-6848 (2001).
117. +T cells by TGF-β I through a p38 mitogen-activated protein kinase-dependent pathway. J. Immunol. 165, 5011-5016 (2000).
118. Crocker, P.R. & Varki, A. Siglecs in the immune system. Immunology 103, 137-145 (2001).
119. Cornall, R. J., Goodnow, C. C. & Cyster, J. G. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHPI pathway. Curr. Top. Microbiol. Immunol. 244, 57-68 (1999).
120. Jin, L, McLean, P.A., Neel, B. G. & Wortis, H. H. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 195, 1199-1205 (2202).
121. Razi, N. & Varki, A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl. Acad. Sci. USA 95, 7469-7474 (1998).
122. Kelm, S., Gerlach, J., Brossmer, R., Danzer, C. P. & Nitschke, L. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 195, 1207-1213 (2002).
123. + T cells. J. Immunol. 166, 3865-3872 (2001).
124. Cramer, S.O. et al. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int. Immunol. 12, 1347-1351 (2000).
125. Lechmann, M. et al. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194, 1813-1821 (2001).
126. Scholler, N. et al. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 168, 2599-2602 (2002).
127. +T cell development in the thymus. Cell 108, 755-767 (2002).
128. Hughes, R. C. Galectins, as modulators of cell adhesion. Biochimie 83, 667-676 (2001).
129. Perillo, N. L., Pace, K. E., Seilhamer, J.J. & Baum, L. G. Apoptosis of T cells mediated by galectin-1. Nature 378, 736-739 (1995).
130. Perillo, N. L., Uittenbogaart, C. H., Nguyen, J.T. & Baum, L. G. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J. Exp. Med. 185, 1851-1858 (1997).
131. Vespa, G. N. et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J. Immunol. 162, 799-806 (1999).
132. Chung, C. D., Lewis, L. A. & Miceli, M. C. T cell antigen receptor-induced IL-2 production and apoptosis have different requirements for Lck activities. J. Immunol. 159, 1758-1766 (1997).
133. Wada, J., Ota. K., Kumar, A., Wallner, E.I. & Kanwar, Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J. Clin. Invest 99, 2452-2461 (1997).
134. Dennis, J.W., Warren, C. E., Granovsky, M. & Demetriou, M. Genetic defects in N-glycosylation and cellular diversity in mammals. Curr. Opin. Struct. Biol. 11, 601-607 (2001).
135. Poirier, F. & Robertson, E.J. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 119, 1229-1236 (1993).
136. Colnot, C., Fowlis, D., Ripoche, M.A., Bouchaert, I. & Poirier, F. Embryonic implantation in galectin I/galectin 3 double mutant mice. Dev. Dyn. 211, 306-313 (1998).
137. Hsu, D. K. et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156, 1073-1083 (2000).